CFO departure
Grove Collaborative Holdings, Inc. discloses CFO departure: Tom Siragusa
Grove Collaborative Holdings, Inc. reported in a Form 8-K filed June 24, 2026 a change involving its Chief Financial Officer, Tom Siragusa, effective August 16, 2026. The filing's own words are quoted below.
In the filing's words
On June 18, 2026, Tom Siragusa, the Chief Financial Officer and Principal Financial Officer of Grove Collaborative Holdings, Inc. (the “Company”), gave notice of his intention to resign as an officer and employee of the Company to pursue another opportunity. Mr. Siragusa will remain in his position until August 16, 2026 (the “Effective Date”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Grove Collaborative Holdings, Inc. (GROV) |
|---|---|
| Event | Departure |
| Outgoing | Tom Siragusa |
| Effective | August 16, 2026 |
| 8-K filed | June 24, 2026 |
| SEC CIK | 0001841761 |
Grove Collaborative Holdings, Inc. reported this change in a Form 8-K, Item 5.02, filed June 24, 2026. The filing's own words are quoted above.
Before and after at Grove Collaborative Holdings, Inc.
The adjacent records in the company's seat timeline.
Other records naming Tom Siragusa
1The outgoing officer on this record, matched by name. Career line.
2026-03-05 · 10-K signature
Tom Siragusa signed Grove Collaborative Holdings, Inc.'s annual report as Chief Financial Officer (Principal Financial and Accounting Officer)
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Tom Siragusa? Send a correction with the primary source.